Yield10 Bioscience, Inc. (YTEN) Research

Yield10 Bioscience, Inc. is an agricultural biotechnology firm dedicated to creating advanced solutions that can significantly boost crop productivity across the United States and Canada. Utilizing its proprietary Trait Factory – an innovative gene discovery platform – the company develops enhanced varieties of oilseed Camelina sativa for exclusive seed products. Additionally, it identifies valuable genetic characteristics applicable to both the agricultural and food sectors. Yield10 Bioscience maintains licensing agreements with several key industry players, including GDM Seeds, J. R. Simplot, Forage Genetics International, LLC, and Bayer AG. The company, incorporated in 1992, rebranded from Metabolix, Inc. to Yield10 Bioscience, Inc. in January 2017. Its corporate headquarters are located in Woburn, Massachusetts.

Market snapshot

Symbol
YTEN
Price
$0.34
Day change
-51.78%
Market cap
$345.5K
P/E ratio
-0.01x
52-week range
0.2352-17.255999
Sector
Basic Materials
Industry
Agricultural Inputs
Analyst price target
$84.64

Peer companies

  • American Vanguard Corporation (AVD)
  • Benson Hill, Inc. (BHIL)
  • Bioceres Crop Solutions Corp. (BIOX)
  • CF Industries Holdings, Inc. (CF)
  • China Green Agriculture, Inc. (CGA)
  • Corteva, Inc. (CTVA)
  • FMC Corporation (FMC)
  • ICL Group Ltd (ICL)

Recent insider activity

  • Snell Kristi — F-InKind (877 shares) on 2024-08-15
  • BRUM LYNNE H — F-InKind (731 shares) on 2024-08-15
  • HAASER CHARLES B — F-InKind (731 shares) on 2024-08-15
  • Peoples Oliver P — F-InKind (1463 shares) on 2024-08-15
  • SCHULER JACK W — S-Sale (36000 shares) on 2023-12-20

Open Yield10 Bioscience, Inc. (YTEN) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.